Dexlansoprazole DDR Pellets
Rraynex supplies Dexlansoprazole DDR Pellets as dual delayed-release pellets in the Anti-Ulcerant (PPIs) category, in strengths of 10%, 17%, 20%, 22.5%.
Product overview
Dexlansoprazole, the R-enantiomer of lansoprazole, is a proton pump inhibitor used for GERD and erosive oesophagitis, typically delivered as dual delayed-release capsules.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Formulation and release profile
Dual delayed-release (DDR) products combine two populations of enteric-coated pellets that dissolve at different pH levels, giving two release phases from a single capsule.
Pharmaceutical applications
- Capsule filling of dexlansoprazole ddr pellets for acid-suppression products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Dexlansoprazole DDR Pellets
- Form
- dual delayed-release Pellets
- Therapeutic category
- Anti-Ulcerant (PPIs)
- Available strengths
- 10%, 17%, 20%, 22.5%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Dexlansoprazole DDR Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Dexlansoprazole products from Rraynex
- Dexlansoprazole — Pellets
- Dexlansoprazole MUPS — Pellets